| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0269881113515065 |
| P8608 | Fatcat ID | release_x4ff4nngqbdxzon2vgh3jowcpq |
| P698 | PubMed publication ID | 24429224 |
| P5875 | ResearchGate publication ID | 259765849 |
| P50 | author | Donatella Marazziti | Q27149392 |
| Liliana Dell'Osso | Q72932960 | ||
| Lionella Palego | Q90229020 | ||
| Mario Catena-Dell''Osso | Q117231910 | ||
| Gino Giannaccini | Q46649946 | ||
| Stefano Baroni | Q57033213 | ||
| Laura Betti | Q57327715 | ||
| P2093 | author name string | Maura Castagna | |
| Antonio G Naccarato | |||
| Antonio Luccachini | |||
| P2860 | cites work | Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects | Q22248075 |
| G-protein-coupled receptor heterodimerization modulates receptor function | Q24603239 | ||
| Serotonin-1A receptor imaging in recurrent depression: replication and literature review | Q24657080 | ||
| Increased baseline occupancy of D2 receptors by dopamine in schizophrenia | Q24676113 | ||
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
| Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain | Q28215641 | ||
| Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors | Q28273285 | ||
| Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action | Q28283418 | ||
| [3H]WAYâ 100635 for 5â HT1A receptor autoradiography in human brain: a comparison with [3H]8â OHâ DPAT and demonstration of increased binding in the frontal cortex in schizophrenia | Q29010594 | ||
| 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex | Q33912242 | ||
| Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors. | Q34062862 | ||
| Is there a role for 5-HT1A agonists in the treatment of depression? | Q34174041 | ||
| 8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production | Q34280784 | ||
| Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study | Q34473925 | ||
| Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT | Q34558558 | ||
| 5-HT1A receptor agonist properties of antipsychotics determined by [35S]GTPgammaS binding in rat hippocampal membranes | Q34619843 | ||
| Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties. | Q34677182 | ||
| Molecular characterization of antipeptide antibodies against the 5-HT1A receptor: evidence for state-dependent antibody binding | Q34743905 | ||
| Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? | Q34809553 | ||
| Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders | Q35810041 | ||
| Pharmacological characterization of acetylcholine-stimulated [35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: antagonist studies | Q36329758 | ||
| Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis | Q37260903 | ||
| Where to Position Clozapine: Re-Examining the Evidence | Q37801988 | ||
| Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems | Q37825633 | ||
| Prefrontal function in schizophrenia: confounds and controversies | Q41242094 | ||
| Reduced basal and stimulated (isoprenaline, Gpp(NH)p, forskolin) adenylate cyclase activity in Alzheimer's disease correlated with histopathological changes | Q42476813 | ||
| Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims | Q42499061 | ||
| Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor | Q43177165 | ||
| The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia | Q43601443 | ||
| Dopamine D1-stimulated adenylyl cyclase activity in cerebral cortex of autopsied human brain | Q43641375 | ||
| Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635. | Q44014139 | ||
| Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism | Q44225342 | ||
| Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study | Q44317508 | ||
| Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice | Q44521481 | ||
| Effects of clozapine and its metabolites on the 5-HT2 receptor system in cortical and hippocampal cells in vitro | Q44748275 | ||
| Involvement of G protein betagamma-subunits in diverse signaling induced by G(i/o)-coupled receptors: study using the Xenopus oocyte expression system | Q44902163 | ||
| Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism | Q45056326 | ||
| Cloned human 5-HT1A receptor pharmacology determined using agonist binding and measurement of cAMP accumulation | Q45105452 | ||
| (R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex | Q48243441 | ||
| Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions | Q48309573 | ||
| Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues. | Q48313093 | ||
| Pharmacological characterization of the 5-hydroxytryptamine receptor coupled to adenylyl cyclase stimulation in human brain | Q48359039 | ||
| Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissue | Q48419142 | ||
| Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum | Q48486128 | ||
| 5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine | Q48594004 | ||
| Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia | Q49119845 | ||
| Behavioral effects of flibanserin (BIMT 17). | Q51087336 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 320-328 | |
| P577 | publication date | 2014-01-15 | |
| P1433 | published in | Journal of Psychopharmacology | Q6295819 |
| P1476 | title | Clozapine effects on adenylyl cyclase activity and serotonin type 1A receptors in human brain post-mortem | |
| P478 | volume | 28 |
Search more.